What Does Director Kirwin's Recent Insider Buy Signal for ProMIS Neurosciences

Related Articles

ProMIS Neurosciences' PMN310: Differentiated Safety Profile Unlocks Alzheimer's Upside

1 months ago

What is Driving Jupiter Neurosciences' Recent Stock Volatility

3 months ago

What Does Microsoft's Recent Insider Purchase Signal

6 months ago

What Does Recent Insider Activity at S&P Global (SPGI) Signal

3 months ago

Category

You may also like

Stock News•3 weeks ago

ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026

ProMIS Neurosciences will report Q2 2026 financial results and a business update on Aug. 13, 2026, followed by an investor call at 4:30 p.m. ET, per a company announcement.

PMN

Share

Stock News•3 weeks ago

Ionis Pharmaceuticals Director Hayden Buys $1.1 Million Shares. What Does This Mean for Investors?

Ionis Pharmaceuticals director Hayden bought 20,000 shares for ~$1.1 million, raising his direct and indirect holdings by 34%, signaling insider confidence.

IONS

Share

Stock News•1 months ago

Playing The Biotech Breakout With Insiders

AbCellera Biologics and Alpha Cognition are highlighted for insider buying and revenue growth. ABCL's Phase 2 data for ABCL635 in Q3 and ACOG's Zunveyl sales ramp are key catalysts, with analyst targe...

ABCL

Share

Stock News•1 months ago

What This MannKind Filing Reveals About Three Years of Underperformance

An insider reduced MannKind holdings by 46,795 shares, a 9% cut to direct equity. The filing highlights prolonged underperformance over three years.

MNKD

Share